Suchergebnisse - "Sparks, Jeffrey A"

PubPharm (27)

1

Breakthrough COVID-19 After Tixagevimab/Cilgavimab Among Patients With Systemic Autoimmune Rheumatic Diseases

enthalten in: The Journal of rheumatology | 2024

von Kawano, Y. | Wang, X. | Patel, N. | +10

2

Associations of DMARDs with post-acute sequelae of COVID-19 in patients with systemic autoimmune rheumatic diseases : a prospective study

enthalten in: Rheumatology (Oxford, England) | 2023

von Venkat, R. | Wang, X. | Patel, N. | +12

3

Risk factors and outcomes for repeat COVID-19 infection among patients with systemic autoimmune rheumatic diseases : A case-control study

enthalten in: Seminars in arthritis and rheumatism | 2023

von Kowalski, E. | Wang, X. | Patel, N. | +9

4

Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era : a Narrative Review

enthalten in: Current rheumatology reports | 2023

von Venkat, R. | Wallace, Z. | Sparks, J.

5

Immunomodulators and risk for breakthrough infection after third COVID-19 mRNA vaccine among patients with rheumatoid arthritis : A cohort study

enthalten in: medRxiv : the preprint server for health sciences | 2023

von Schiff, A. | Wang, X. | Patel, N. | +12

UpdateIn: Ann Rheum Dis. 2024 Jan 10;:. - PMID 38199795

6

Considerations for Pharmacologic Management of Rheumatoid Arthritis in the COVID-19 Era: a Narrative Review

enthalten in: Current rheumatology reports | 2023

von Venkat, R. | Wallace, Z. | Sparks, J.

7

Response to : Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by van Vollenhoven et al

enthalten in: Annals of the rheumatic diseases | 2023

von Sparks, J. | Wallace, Z. | Seet, A. | +3

8

Response to : Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 Global Rheumatology Alliance physician registry" by Sparks et al

enthalten in: Annals of the rheumatic diseases | 2023

von Wallace, Z. | Sparks, J. | Robinson, P. | +2

CommentOn: Ann Rheum Dis. 2021 Sep;80(9):1137-1146. - PMID 34049860

9

Response to : 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C et al

enthalten in: Annals of the rheumatic diseases | 2023

von D'Silva, K. | Serling-Boyd, N. | Hsu, T. | +2

CommentOn: Ann Rheum Dis. 2021 Jun;80(6):817-819. - PMID 33436385

10

Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19

enthalten in: BMC medicine | 2023

von Wei, J. | Zhang, W. | Doherty, M. | +7